An ELRIG webinar has explored how cell-based screening supports drug discovery, from early target validation to advanced ...

When we hear that a person has quirks, we expect to be charmed. But when we hear that a cell-based assay has quirks, we expect to be frustrated. Quirks in cell-based assays tend to complicate drug ...

SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory ...

This article examines the key differences between primary and secondary screening in drug discovery, detailing how primary ...

This article outlines the characteristics, advantages, and limitations of 96‑, 384‑, and 1536‑well plates for high-throughput ...